» Articles » PMID: 30630521

Early Diuretic Use and Mortality in Critically Ill Patients with Vasopressor Support: a Propensity Score-matching Analysis

Overview
Journal Crit Care
Specialty Critical Care
Date 2019 Jan 12
PMID 30630521
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The effect of loop diuretic use in critically ill patients on vasopressor support or in shock is unclear. This study aimed to explore the relationship between loop diuretic use and hospital mortality in critically ill patients with vasopressor support.

Methods: Data were extracted from the Medical Information Mart for Intensive Care III database. Adult patients with records of vasopressor use within 48 h after intensive care unit admission were screened. Multivariable logistic regression and propensity score matching was used to investigate any association.

Results: Data on 7828 patients were included. The crude hospital mortality was significantly lower in patients with diuretic use (166/1469 vs. 1171/6359, p <  0.001). In the extended multivariable logistic models, the odds ratio (OR) of diuretic use was consistently significant in all six models (OR range 0.56-0.75, p < 0.05 for all). In the subgroup analysis, an interaction effect was detected between diuretic use and fluid balance (FB). In the positive FB subgroup, diuretic use was significantly associated with decreased mortality (OR 0.64, 95% confidence interval (CI) 0.51-0.78) but was insignificant in the negative FB subgroup. In the other subgroups of mean arterial pressure, maximum sequential organ failure assessment score, and lactate level, the association between diuretic use and mortality remained significant and no interaction was detected. After propensity score matching, 1463 cases from each group were well matched. The mortality remained significantly lower in the diuretic use group (165/1463 vs. 231/1463, p < 0.001).

Conclusions: Although residual confounding cannot be excluded, loop diuretic use is associated with lower mortality.

Citing Articles

Prediction of acute kidney injury in intensive care unit patients based on interpretable machine learning.

Zhang L, Li M, Wang C, Zhang C, Wu H Digit Health. 2025; 11():20552076241311173.

PMID: 39777058 PMC: 11705319. DOI: 10.1177/20552076241311173.


Association between metabolic dysfunction associated steatotic liver disease and gallstones in the US population using propensity score matching.

Zhang Y, Zhang J, Yu D, Tu F, Liu J, Han B Sci Rep. 2025; 15(1):910.

PMID: 39762481 PMC: 11704231. DOI: 10.1038/s41598-025-85218-5.


The potential effectiveness of tolvaptan in critically ill patients including cardiac and noncardiac populations: a retrospective observational study.

Yamazaki Y, Niwa H, Ishiyama E, Hori M, Sugo Y, Hirota K Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39556149 DOI: 10.1007/s00210-024-03618-2.


Clinical Features of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor versus Non-Immune Checkpoint Inhibitor Drugs in China: A Cross-Sectional Study and Literature Review.

Qin K, Gong T, Ruan S, Lin M, Su X, Lv X J Inflamm Res. 2024; 17:7591-7605.

PMID: 39464339 PMC: 11512543. DOI: 10.2147/JIR.S491791.


The Urine Output Response to Low-Dose Diuretic Challenge Predicts Tolerance to Negative Fluid Balance in Mechanically Ventilated, Critically Ill Patients.

Kataoka J, Uchimido R, Santanda T, Nabeshima T, Fujimoto Y, Norisue Y Cureus. 2024; 16(7):e65824.

PMID: 39219915 PMC: 11363010. DOI: 10.7759/cureus.65824.


References
1.
Mehta R, Pascual M, Soroko S, Chertow G . Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 2002; 288(20):2547-53. DOI: 10.1001/jama.288.20.2547. View

2.
Uchino S, Doig G, Bellomo R, Morimatsu H, Morgera S, Schetz M . Diuretics and mortality in acute renal failure. Crit Care Med. 2004; 32(8):1669-77. DOI: 10.1097/01.ccm.0000132892.51063.2f. View

3.
Wiedemann H, Wheeler A, Bernard G, Thompson B, Hayden D, deBoisblanc B . Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006; 354(24):2564-75. DOI: 10.1056/NEJMoa062200. View

4.
Ho K, Sheridan D . Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ. 2006; 333(7565):420. PMC: 1553510. DOI: 10.1136/bmj.38902.605347.7C. View

5.
Coats T, Brazil E, Heron M, MacCallum P . Impairment of coagulation by commonly used resuscitation fluids in human volunteers. Emerg Med J. 2006; 23(11):846-9. PMC: 2464380. DOI: 10.1136/emj.2006.036574. View